Katharina A. Sterenczak

Author

University of Veterinary Medicine Hannover, Foundation ORCID

Also Known As

K Sterenczak, K. A. Sterenczak, Katharina A Sterenczak, Katharina A. Sterenczak, Katharina Anna Sterenczak, Katharina Sterenczak, Katharina A. Sterenczak, Sterenczak, Katharina A.

Publications

360

Citations

H-Index

Concepts

All Affiliations

University of Veterinary Medicine Hannover, Foundation University of Rostock University of Veterinary Medicine Vienna University of Bremen Karlsruhe Institute of Technology

About

Katharina A. Sterenczak is an author at University of Veterinary Medicine Hannover, Foundation specializing in gene expression, medicine, and transcriptional regulation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	64
2	Natural Sciences	1	1	47
3	Cell Biology	1	1	17
4	Immunology	1	1	17
5	Molecular Biology	1	1	47

Katharina A. Sterenczak

Publications

254

Citations

H-Index

Page 1

	Year	Citations
Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms Katharina A. Sterenczak, Saskia Willenbrock, Matthias Barann, Gene Transcriptional RegulationSystems BiologyMolecular PhysiologySignal TransductionProtein Expression	2008	47
HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28and let-7 miRNAs in oral squamous cell carcinoma Katharina A. Sterenczak, A. Eckardt, Andreas Kampmann, BMC Cancer	2014	31
Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer Katharina A. Sterenczak, Martin Meier, Silke Glage, BMC Cancer	2012	25
Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines. Mohammed Moulay, Wen Liu, Saskia Willenbrock, PubMed	2013	21
Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258 M. Fork, Hugo Murua Escobar, Jan T. Soller, BMC Cancer	2008	21
Morphological characterization of the human corneal epithelium by in vivo confocal laser scanning microscopy Katharina A. Sterenczak, Karsten Winter, Karsten Sperlich, Quantitative Imaging in Medicine and Surgery	2021	19
High-mobility group B1 (HMGB1) and receptor for advanced glycation end-products (RAGE) expression in canine lymphoma. Katharina A. Sterenczak, A. Joetzke, Saskia Willenbrock, PubMed	2010	17
Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation Leila Taher, Julia Beck, Ryan Wen Liu, Scientific Reports ImmunologyPathologyTranscriptomics TechnologyTumor BiologyTumor Heterogeneity	2018	17
Quantitative PCR and immunohistochemical analyses of HMGB1 and RAGE expression in canine disseminated histiocytic sarcoma (malignant histiocytosis). Katharina A. Sterenczak, Sven Kleinschmidt, Patrick Wefstaedt, PubMed	2011	15
Burst of Corneal Dendritic Cells during Trastuzumab and Paclitaxel Treatment Katharina A. Sterenczak, Nadine Stache, Sebastian Bohn, Diagnostics	2021	15

Page 1